
    
      All subjects will be given the same treatment regimen of total body irradiation (TBI),
      Fludarabine, Cyclophosphamide, and anti-thymocyte globulin (ATG), followed by an alternate
      donor stem cell transplant. Since this treatment regimen has been given before, without
      thymic shielding, we will compare the outcomes of these patients with the historical data
      from subjects who did not receive thymic shielding.
    
  